IPASS

NCT00322452 📎

Regimen

Experimental
gefitinib
Control
carboplatin+paclitaxel

Population

East Asian never/light-smoker adenocarcinoma, clinically selected

Key finding

In EGFR-mut subset PFS HR 0.48 (0.36-0.64); in EGFR-WT HR 2.85 (2.05-3.98); proved EGFR status is predictive

Source: PMID 19692680

Timeline

  • Enrollment start: 2006-03 📎

Guideline citations

  • CSCO NSCLC 2025 ⚠️ OCR source